RTA408 significantly reduces RGCs loss in glaucoma. by Hongmei Qian (538647)

Age-standardized prevalence rates of gynecological diseases across 21 GBD regions, by SDI, from 1990 to 2021. by Xiaofeng He (2618752)

Subjects:

Additional questions on vaccination. by Sara Saleh (6733619)

Subjects:

The raw data file. by Sara Saleh (6733619)

Subjects:

Results of SD-TOPSIS application ‐ combination A. by Roman Vavrek (13200141)

“…<div><p>The performance evaluation of local self-government entities is very difficult, as their primary goal is not to make a profit, but to provide services to their residents that will contribute to an increase in their quality of life. …”

Age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Prevalence and trends of gynecological diseases (GDs) among women of childbearing age, by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Prevalence of gynecological diseases (GDs) among women of childbearing age in 2021, along with their changes from 1990 to 2021, and the contribution of each GD to the overall preva... by Xiaofeng He (2618752)

Subjects:

Fig 1 - by Sara Hintze (3216885)

Subjects:

Ethogram describing all outcome measures. by Sara Hintze (3216885)

Subjects:

Test apparatus. by Sara Hintze (3216885)

Subjects:

The raw data used in this study. by Yu Fu (16582)

Subjects:

Fig 3 - by Sara Hintze (3216885)

Subjects:

Disease burden trends of leukemia and lymphoma analyzed by joinpoint regression analysis in mainland China. by Yu Fu (16582)

Subjects:

Disease burden trends of multiple myeloma and other hematological neoplasms analyzed by joinpoint regression analysis in mainland China. by Yu Fu (16582)

Subjects:

Projections of incidence for hematological malignancies in mainland China. by Yu Fu (16582)

Subjects:

Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for leukemia in mainland China. by Yu Fu (16582)

Subjects:

Projections of mortality for hematological malignancies in mainland China. by Yu Fu (16582)

Subjects: